Casdin Capital, LLC - LIANBIO ownership

LIANBIO's ticker is and the CUSIP is 53000N108. A total of 41 filers reported holding LIANBIO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of LIANBIO
ValueSharesWeighting
Q3 2023$307,558
-34.6%
206,4150.0%0.03%
-17.1%
Q2 2023$470,626
+16.9%
206,4150.0%0.04%
+24.2%
Q1 2023$402,509
+18.9%
206,4150.0%0.03%
+26.9%
Q4 2022$338,521
-17.6%
206,4150.0%0.03%
-3.7%
Q3 2022$411,000
-7.8%
206,4150.0%0.03%
-28.9%
Q2 2022$446,000
-41.8%
206,4150.0%0.04%
+11.8%
Q1 2022$766,000
-39.8%
206,4150.0%0.03%
-5.6%
Q4 2021$1,272,000206,4150.04%
Other shareholders
LIANBIO shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 112,639,920$693,862,0005.35%
Vida Ventures Advisors, LLC 2,282,084$14,058,0005.26%
VR Adviser, LLC 5,378,341$33,131,0004.53%
SCHF (GPE), LLC 937,500$5,775,0001.04%
RA Capital Management 7,655,015$47,155,0000.83%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,314,173$20,415,0000.61%
Logos Global Management LP 412,837$2,543,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,782,747$10,982,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 275,007$1,662,0000.18%
Affinity Asset Advisors, LLC 72,406$446,0000.16%
View complete list of LIANBIO shareholders